Skip to content

AUROBINDO

Active
Public limited companyfounded 20196 yrs activeBurgemeester Etienne Demunterl. 5, 1090 Jette, BelgiumKBO/BCE: BE 0739.963.411
Summary

AUROBINDO has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €13.1m and a net result of €2.2m. Equity is growing by ~28.4% per year across the filed fiscal years. Its solvency ranks better than 64% of 219 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.4% (very low).

Risk analysisWatch ReportCompare
AUROBINDOActiveChecked score 85/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
#4 company by equity in Jette, Wholesale and retail trade sector1 site
Size
€28.6mturnover 2026
Staff
35.3 FTE
Equity
€13.1m
Profit
€2.2m
Financial health
85 Excellent Checked score 2026
Bankruptcy chance 12 m
0.4%
Structure
Parent
Agile Pharma BV · 100%
Accounts 47 d early1 of 11 deeds read
Why 85- Liquidity: current ratio 2.16, cash €64,961- Founded in 2019+ Size: turnover €28.6m, 35.3 FTE, total assets €22.0m+ Profit of €2.2m (FY 2026)Show the evidence

Checked score

Score 2026
85 / 100
Excellent
Probability in this band: under 0.55%
Better than 65% of its sector peers (NACE 46, small)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2025
Strong
Solvency 85-8
equity 59.8% of total assets
Liquidity 31-6
short-term debt 40.2% · cash 0.3%
Profitability 75+2
return on assets 10.1%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (4,366 companies)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● 0.0% vs 11-2024 01-2025: 0.4%▲ +0.2% vs 12-2024 02-2025: 0.4%● 0.0% vs 01-2025 03-2025: 0.4%● 0.0% vs 02-2025 04-2025: 0.4%▼ -5.0% vs 03-2025 05-2025: 0.4%▼ -3.6% vs 04-2025 06-2025: 0.4%▲ +1.4% vs 05-2025 07-2025: 0.4%▲ +7.7% vs 06-2025 08-2025: 0.4%▼ -2.5% vs 07-2025 09-2025: 0.4%▲ +11.9% vs 08-2025highest value 10-2025: 0.4%▼ -14.5% vs 09-2025 11-2025: 0.4%● 0.0% vs 10-2025 12-2025: 0.4%● 0.0% vs 11-2025 01-2026: 0.4%● 0.0% vs 12-2025 02-2026: 0.4%▲ +1.6% vs 01-2026 03-2026: 0.3%▼ -12.0% vs 02-2026 04-2026: 0.3%● 0.0% vs 03-2026 05-2026: 0.3%▼ -5.6% vs 04-2026lowest value 06-2026: 0.3%▲ +1.9% vs 05-2026 07-2026: 0.3%▲ +8.0% vs 06-2026 08-2026: 0.4%▲ +3.7% vs 07-2026 09-2026: 0.4%▲ +9.4% vs 08-2026 10-2026: 0.4%▲ +3.8% vs 09-2026
  • Liquidity: current ratio 2.16, cash €64,961 raises the probability
  • Founded in 2019 raises the probability for this profile
  • Size: turnover €28.6m, 35.3 FTE, total assets €22.0m lowers the probability for this profile
  • Profit of €2.2m (FY 2026) lowers the probability
Credit up to €1,100,000 at 30 days acceptable
Liquidity ample (current ratio 2.16 against 2.5 in 2025; short-term debt: 40.2% and cash: 0.3% of total assets), and 40.2% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 46, small). Better than this share of them on solvency 69%, liquidity 32%, profitability 71%, growth against the median 87%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Liquidity: current ratio 2.16, cash €64,961
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Founded in 2019
In the bankruptcy model this factor raises the probability for this profile.
KBO
lowers risk · Size: turnover €28.6m, 35.3 FTE, total assets €22.0m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Profit of €2.2m (FY 2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 14-09-2026, 47 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2026
47 d early
2025
46 d early
2024
45 d early
2023
48 d early
2022
45 d early
2021
53 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 47 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. Usually files around 15 September (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
03-10-2026 today31-03-2027 close31-10-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2026 · full…
  2. Resignation: Guy Brits (managing director)State Gazette act
  3. Highest result since 2021net €2.2m ▲42.7%

Key points

  • Positive: Company by equity in Jette, Wholesale and retail…in the Checked rankings #4 View
  • Controlled by Agile Pharma BVknown shareholders 100% 100% View
  • Positive: Result rose in 2026from €1.6m to €2.2m ▲ 42.7% View
  • Positive: Always filed on timeaccounts within the deadline every year 6 years View
  • Positive: 3 years of growth in a rowturnover 2026: €28.6m 3 years View
  • A director leftlatest change 27-07-2026 · 0 in office 1 left View

By topic

Financials

Fiscal year
2026
Turnover
€28.6m
Profit
€2.2m
Solvency
59.8%
Turnover▲ 23.9%
Net result
20212026
Go to Financials

Timeline

Events
12
Since
2021
Next accounts
by 31-10-2027
  1. 14-09-2026Annual accounts filed
  2. 27-07-2026Resignation: Guy Brits (managing director)
  3. 31-03-2026Highest result since 2021
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
23-12-2019
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure